Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve168 who wrote (17150)	6/10/2003 12:23:23 PM
From: Mr. Sunshine	Read Replies (1) of 78507

Steve, Good job on Vical! I will opine, however, that its rise is in tandem with the biotech sector as a whole and the cancer research stocks (largely due to Imclone's recent announcement) specifically rather than investors seeing it as a value play. Do not get me wrong, I invest in both value and growth companies, and have come close to investing in Vical several times. I just would not call it a value stock when the burn rate (net loss) is so high. It is all sematics, however. Value or growth, when you are making money it is a good thing! Congratulations! Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next